Table: begin end state 1 21 cytoplasmic 22 47 transmembrane 48 59 non-cytoplasmic 60 79 transmembrane 80 89 cytoplasmic 90 110 transmembrane 111 115 non-cytoplasmic 116 137 transmembrane 138 148 cytoplasmic 149 172 transmembrane 173 178 non-cytoplasmic 179 199 transmembrane 200 255 cytoplasmic 256 281 transmembrane 282 294 non-cytoplasmic 295 316 transmembrane 317 322 cytoplasmic 323 342 transmembrane 343 345 non-cytoplasmic 346 371 transmembrane 372 372 non-cytoplasmic 373 382 cytoplasmic 383 403 transmembrane 404 411 non-cytoplasmic 412 432 transmembrane 433 454 cytoplasmic
Input: >AZOBR_RS26920 FitnessBrowser__azobra:AZOBR_RS26920 MPTARSVDVQAFLNEHPFSRYQWLVFALCFFIVLLDGFDTAAIGYIAPSLTTEWGIARPA LAPVLSAALFGLAFGALSAGPLADRFGRKAILIGSVLVIGTACLASAFSGNLDQLVMLRF VTGLGLGAAMPNAVTLMSEYCPEGRRAMVTNAMFCGFPLGAAFGGFLAAWMIPLWGWRSV LVLGGIAPLVLAAVLLVLLPESVRYMVAHNHPVERIRAVLRRISETAAGAAGFVMTEKAP ATKARNGIAVVLSRGYLVGSVMLWVAYFMGLVIFYALINWMPILFKDAGLAPRDAALIAA LFPLGGVGAVLSGWLMDRFNANRIIAFGFVLTYGAVYAIGQVAGNVGLLVVTVFAAGTIM NTAQTSLPALAASFYPTHGRATGVAWMLGLGRFGGIGGSFLVAELARRQLDFTSIFAIVA VPGLVAALALLVKQFVHPEDRSSGTGRTVEALGH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server